From the Department of Radiology (V.R., S.V., A.Z., T.Y.P.), Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Pediatric Oncology (P.K., W.B.L., K.D.W.), Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
AJNR Am J Neuroradiol. 2023 Jul;44(7):833-840. doi: 10.3174/ajnr.A7910. Epub 2023 Jun 15.
Molecular profiling is a crucial feature in the "integrated diagnosis" of CNS tumors. We aimed to determine whether radiomics could distinguish molecular types of pontine pediatric high-grade gliomas that have similar/overlapping phenotypes on conventional anatomic MR images.
Baseline MR images from children with pontine pediatric high-grade gliomas were analyzed. Retrospective imaging studies included standard precontrast and postcontrast sequences and DTI. Imaging analyses included median, mean, mode, skewness, and kurtosis of the ADC histogram of the tumor volume based on T2 FLAIR and enhancement at baseline. Histone H3 mutations were identified through immunohistochemistry and/or Sanger or next-generation DNA sequencing. The log-rank test identified imaging factors prognostic of survival from the time of diagnosis. Wilcoxon rank-sum and Fisher exact tests compared imaging predictors among groups.
Eighty-three patients had pretreatment MR imaging and evaluable tissue sampling. The median age was 6 years (range, 0.7-17 years); 50 tumors had a K27M mutation in and 11, in . Seven tumors had histone H3 K27 alteration, but the specific gene was unknown. Fifteen were H3 wild-type. Overall survival was significantly higher in compared with mutant tumors ( = .003) and in wild-type tumors compared with any histone mutation ( = .001). Lower overall survival was observed in patients with enhancing tumors ( = .02) compared with those without enhancement. -mutant tumors showed higher mean, median, and mode ADC_total values (< .001) and ADC_enhancement (< .004), with lower ADC_total skewness and kurtosis (< .003) relative to -mutant tumors.
ADC histogram parameters are correlated with histone H3 mutation status in pontine pediatric high-grade glioma.
分子谱分析是中枢神经系统肿瘤“综合诊断”的一个关键特征。我们旨在确定放射组学是否可以区分桥脑儿童高级别胶质瘤的分子类型,这些肿瘤在常规解剖磁共振图像上具有相似/重叠的表型。
对患有桥脑儿童高级别胶质瘤的儿童进行基线磁共振成像分析。回顾性影像学研究包括标准的对比前和对比后序列以及弥散张量成像。影像学分析包括基于 T2 FLAIR 和基线强化的肿瘤体积 ADC 直方图的中位数、平均值、众数、偏度和峰度。通过免疫组化和/或 Sanger 或下一代 DNA 测序确定组蛋白 H3 突变。对数秩检验确定从诊断时开始预测生存的影像学因素。Wilcoxon 秩和检验和 Fisher 精确检验比较组间的影像学预测因子。
83 例患者有预处理磁共振成像和可评估的组织取样。中位年龄为 6 岁(范围,0.7-17 岁);50 个肿瘤在 中存在 K27M 突变,在 中存在 11 个突变。7 个肿瘤存在组蛋白 H3 K27 改变,但具体基因未知。15 个为 H3 野生型。与突变肿瘤相比,总体生存率在 中显著更高(=.003),与任何组蛋白突变相比,在野生型肿瘤中更高(=.001)。与无强化肿瘤相比,强化肿瘤患者的总生存率较低(=.02)。与 -突变肿瘤相比,-突变肿瘤的 ADC_total 值(平均值、中位数和众数)(< .001)和 ADC_enhancement(< .004)更高,ADC_total 偏度和峰度(< .003)更低。
ADC 直方图参数与桥脑儿童高级别胶质瘤的组蛋白 H3 突变状态相关。